You are here: Industry Insights > Pharma Experts

News List

The Race to Reinvent Antibiotics: Why Innovation and Access Must Go Hand in Hand Neeta Ratanghayra
April 09, 2025
Register to Download PPT and View Why Innovation and Access Must Go Hand in Hand
Charting Pharma’s Future: How Mergers and Acquisitions Are Reshaping the Industry Landscape Neeta Ratanghayra
December 17, 2024
In Q3 2024 (GlobalData’s Deals Database), the pharmaceutical sector saw 420 M&A deals valued at $32.4 billion, underscoring the ongoing importance of these transactions in shaping the future of the industry.
Cell and Gene Therapy Manufacturing: Operational Challenges and Strategic Considerations Neeta Ratanghayra
December 20, 2024
Producing CGTs requires highly specialized infrastructure, precise processes, and significant investments, making the manufacturing landscape both complex and costly.
Decoding the Role of Synthetic Biology in Pharmaceuticals Neeta Ratanghayra
October 16, 2024
Recognized for its transformative potential, synthetic biology has emerged as a technology poised to revolutionize various industries, including pharmaceuticals.
Navigating the Landscape of Rare Diseases: Current Trends and Future Perspectives Neeta Ratanghayra
September 29, 2024
Rising Investment and Market Dynamics, Future Perspectives in the Orphan Drug Market and The Scenario in China.
Immuno-Oncology: Current Market Landscape and Future Trends（1） Neeta Ratanghayra
September 18, 2024
Immune Checkpoint Inhibitors & Challenges and Future Directions.
Gut Hormone-Based Pharmacotherapies for Obesity Neeta Ratanghayra
April 28, 2024
The history of pharmacotherapy for obesity is marked by a series of promising drugs that were withdrawn due to safety concerns.
The Evolving Landscape of Heart Failure Therapies Neeta Ratanghayra
January 31, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.
What's happening in HF therapies Neeta Ratanghayra
January 02, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.The severity of the disease warrants the development of innovative solutions to address the current treatment gap.
Antibody-Drug Conjugates - Lessons Learned Neeta Ratanghayra
May 20, 2022
Antibody-drug conjugates (ADCs) have made significant progress in tumor therapy and show a promising future.